title: Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens.
abstract: A major new challenge for vaccine development is to target APC such as monocytes and macrophages for efficient Ag processing and presentation. It has been shown that Fc gamma R-mediated uptake of Ag-antibody complexes can enhance Ag presentation by myeloid cells at least 100-fold, and directing Ag to Fc gamma R in mice brings about a substantial increase in the effectiveness of immunization while eliminating the requirement for adjuvant. It has not been determined which of the three subclasses of human Fc gamma R on myeloid cells (Fc gamma RI, Fc gamma RII, or Fc gamma RIII) function to enhance Ag presentation. We have targeted our Ag (TT) to each of the three subclasses of human Fc gamma R on monocytes using Fc gamma R subclass-specific mAb-TT conjugates, and have measured TT presentation by monitoring T cell proliferation in response to TT. In addition, we have examined enhanced Ag presentation mediated by a human IgG1 (HIgG1) anti-TT mAb. All anti-Fc gamma R-TT conjugates enhanced Ag presentation. HIgG1 anti-TT, in monomeric form, enhanced Ag presentation through Fc gamma RI only. Anti-Fc gamma RI-Ag conjugates appear to be optimal for application as vaccines. They are monocyte/macrophage-specific, are very efficiently processed and presented, and enhance Ag presentation despite occupation of Fc gamma RI with HIgG.
authors.affiliation: Department of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.
authors.forename: E J
authors.initials: EJ
authors.lastname: Gosselin
authors.forename: K
authors.initials: K
authors.lastname: Wardwell
authors.forename: D R
authors.initials: DR
authors.lastname: Gosselin
authors.forename: N
authors.initials: N
authors.lastname: Alter
authors.forename: J L
authors.initials: JL
authors.lastname: Fisher
authors.forename: P M
authors.initials: PM
authors.lastname: Guyre
mesh_terms: D000917:Antibody Formation; D000938:Antigen-Presenting Cells / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D008264:Macrophages / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology*; D013745:Tetanus Toxoid / Q000008:administration & dosage; D014612:Vaccines / Q000276:immunology*
chemical_list: D017452:Receptors, IgG; D013745:Tetanus Toxoid; D014612:Vaccines